Document

making Praluent the lowest priced patient-administered monoclonal

Ref for both the 75 mg and 150 mg doses Release House Oversight Committee — Epstein Estate Records (Nov 2025) 1 pages

Epstein Suite indexes the text; the original document lives at its official source. We don't host the original file — view it on the official release to read it in full.

View the original on the official release

Document text

Text is machine OCR and may contain errors. Confirm against the original source above.

making Praluent the lowest priced patient-administered monoclonal

Have a question about what this document contains?

Ask the documents